二磷酸腺肝钠盐

二磷酸腺肝钠盐 基本信息
CAS号 1172-42-5 分子式 C10H15N5O10P2.Na
分子量 450.19173 精确质量  450.01919
PSA  252.22000 LogP  -1.16480

等价的CAS号:

1172-42-5,2092-65-1,16178-48-6,20398-34-9,71997-33-6,71997-36-9,71997-52-9,71997-55-2

基本信息 展开↓

CAS号:
1172-42-5
3D弹球模型:
立即前往扯扯看
分子式:
C10H15N5O10P2.Na
分子量:
450.19173
中文名称:
二磷酸腺肝钠盐
英文名称:
Adenosine 5'-(trihydrogen diphosphate), sodium salt (1:1)
中文别名:
二磷酸腺肝钠盐
英文别名:
Adenosine 5'-(trihydrogen diphosphate), sodium salt (1:1);
Adenosine 5'-(trihydrogen diphosphate), monosodium salt (9CI);
Adenosine 5'-(trihydrogen pyrophosphate), monosodium salt (8CI);
Adenosine 5'-pyrophosphate, sodium salt (7CI);
Adenosine-5'-diphosphate monosodium salt;
NSC 20267;
Sodium ADP
精确分子量/精确质量:
450.01919
极性分子表面积/PSA:
252.22000
油水分配系数/LogP:

LogP值指的是某物质在正辛醇/水两相体系中的分配系数的对数值,反映了物质在油水两相中的分配情况。其中、LogP值越大,说明该物质越亲油;反之,LogP值越小,则说明该物质越亲水。
EINECS:
214-631-6
PubChem:
24853790
InChI:
The Key: NYEHFIIOXORNJT-MCDZGGTQSA-K

物化性质展开↓

密度:
2.49g/cm3
沸点:
877.7ºC at 760mmHg
闪点:
484.6ºC
蒸汽压:
5.8E-33mmHg at 25°C

合成路线查看所有的合成路线

  • 53355-60-5

    5'-O-(4,6-二羟基-2,4,6-三羟基-1,3,5,2,4,6-三噁三磷杂己环-2-基)腺苷

  • 606-67-7

    calcium,5-(cyclohexen-1-yl)-5-ethyl-6-oxopyrimidine-2,4-diolate

  • +

  • 1172-42-5

    二磷酸腺肝钠盐

  • 7659-75-8

    adenosine (5'-phosphoro-1-piperidinide)

  • 1172-42-5

    二磷酸腺肝钠盐

  • 58-61-7

    腺苷

  • 1172-42-5

    二磷酸腺肝钠盐

MSDS 展开↓

Name: Adenosine 5 -diphosphate monosodium salt dihydrate 98% Material Safety Data Sheet
Synonym: ADP-sodium dihydrate
CAS: 1172-42-5
Section 1 - Chemical Product   MSDS Name:Adenosine 5 -diphosphate monosodium salt dihydrate 98% Material Safety Data Sheet
Synonym:ADP-sodium dihydrate

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
1172-42-5 Adenosine 5'-diphosphate, monosodium s 98 unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
  EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. The toxicological properties of this material have not been fully investigated.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
  Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
  General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
  General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal. Provide ventilation.

Section 7 - HANDLING and STORAGE
  Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Avoid breathing dust.
Storage:
Keep refrigerated. (Store below 4C/39F.) Keep container closed when not in use. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
  Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1172-42-5: CAS# 125567-28-4: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
 
Physical State: Crystalline powder
Color: white
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density:
Molecular Formula: C10H14NaN5O10P2.2H2O
Molecular Weight: 485.21

Section 10 - STABILITY AND REACTIVITY
  Chemical Stability:
Stability unknown.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of phosphorus, carbon dioxide, sodium oxide.
Hazardous Polymerization: Will not occur.

Section 11 - TOXICOLOGICAL INFORMATION
  RTECS#:
CAS# 1172-42-5 unlisted.
CAS# 125567-28-4 unlisted.
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Adenosine 5'-(trihydrogen diphosphate), monosodium salt anhydrous - Not listed by ACGIH, IARC, or NTP.
Adenosine 5'-diphosphate, monosodium salt dihydrate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION
 

Section 13 - DISPOSAL CONSIDERATIONS
  Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION
 
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION
 
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1172-42-5: No information available.
CAS# 125567-28-4: No information available.
Canada
CAS# 1172-42-5 is listed on Canada's DSL List.
CAS# 1172-42-5 is not listed on Canada's Ingredient Disclosure List.
CAS# 125567-28-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1172-42-5 is listed on the TSCA inventory.
CAS# 125567-28-4 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游相关产品

上游产品

更多
  • 34051-17-7

    (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(dichlorophosphoryloxymethyl)oxolane-3,4-diol

  • 58-61-7

    腺苷

  • 7659-75-8

    adenosine (5'-phosphoro-1-piperidinide)

  • 53355-60-5

    5'-O-(4,6-二羟基-2,4,6-三羟基-1,3,5,2,4,6-三噁三磷杂己环-2-基)腺苷

立即下载安装“化学加”APP
专业、功能强大,随时调用更加方便